ADVL1615 - Millennium Pharmaceuticals, Inc. - A Phase 1 study of Pevonedistat (MLN4924, IND# 136078), a NEDD8 activating enzyme (NAE) inhibitor, in combination with Temozolomide and Irinotecan in pediatric patients with recurre

Project: Research project

Project Details

StatusActive
Effective start/end date7/1/187/10/21

Funding

  • Children's Hospital of Philadelphia
  • Millennium Pharmaceuticals, Inc